Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372:1733–45.PubMedCrossRefGoogle Scholar
Go VF, Frankakis C, Le Nam V, et al. High HIV sexual risk behaviors and sexually transmitted disease prevalence among injection drug users in Northern Vietnam: implications for a generalized HIV epidemic. J Acquir Immune Defic Syndr. 2006;42:108–15.PubMedCrossRefGoogle Scholar
Des Jarlais DC, Feelemyer JP, Modi SN, et al. Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS One. 2012;7(3):e31227.
Des Jarlais DC, Arasteh,K, McKnigh, C, Hagan H, Perlman DC, Semaan S. Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health 2011;101:1277–1283.
Des Jarlais DC, Arasteh,K, McKnigh, C, Hagan H, Perlman D, Friedman SR. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend. 2009;101(1–2):88–91.
Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003; 80(4): iii7–iii14.
Deiss RG, Lozada RM, Burgos JL, et al. HIV prevalence and sexual risk behaviour among non-injection drug users in Tijuana, Mexico. Global Public Health. 2012;7:175–83.PubMedCrossRefGoogle Scholar
Des Jarlais DC, Semaan S, Arasteh A. AT 30 years: HIV/AIDS and other STDs among persons who use psychoactive drugs. In: Hall BJ, Hall JC, Cockerell CJ, (eds) HIV/AIDS in the post-HAART era: manifestations, treatment, and epidemiology. Shelton, CT: People’s Medical Publishing House; 2011.
Semaan S, Steele B, Des Jarlais DC, Malow R. Methamphetamine use and HIV risk behaviors among heterosexual adolescents and adults in the United States. XVI International AIDS Conference; August 13–18; Toronto; 2006.
Des Jarlais DC, Arasteh K, Perlis T et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS. 2007; 21(2):231–235.
Semaan S, Des Jarlais DC, Sogolow E, Johnson WD, Hedges LV, Ramirez G. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002;30(Suppl 1):S73–93.PubMedGoogle Scholar
Des Jarlais DC, Semaan S. Interventions to reduce the sexual risk behaviour of injecting drug users. Int J Drug Policy 2008;16S: S58–S66.
Semaan S, Des Jarlais DC, Malow R. Behavior change and health-related interventions for heterosexual risk reduction among drug users. Subst Use Misuse. 2006;41:1349–78.PubMedCrossRefGoogle Scholar
Abell-Ollo K, Rahu M, Rajaleid K, et al. Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS Care: Psychol Socio-Med Aspects of AIDS/HIV. 2009;21:851–7.Google Scholar
Meader N, Li R, Des Jarlais DC, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database for Systematic Reviews 2010; Issue 1: CD007195.
Des Jarlais D C, Semaan S. HIV and other sexually transmitted infections in injection drug users and crack cocaine smokers. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen L, Watts DH, editors. Sexually transmitted diseases. 4th ed. New York: Mc-Graw-Hill; 2008.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6):e1000097. doi:10.1371/journal.pmed1000097
National Institute of Health and Clinical Excellence. Guideline development methods. London: NICE; 2008.Google Scholar
Guyatt GH, Oxman AD, Vist GE. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.PubMedCrossRefGoogle Scholar
Johnson WD, Semaan S, Hedges LV. A protocol for the analytical aspects of a systematic review of HIV prevention research. J Acquir Immune Defic Syndr 2002;30 (suppl 1):S62–72.
Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Oxford: Cochrane Collaboration; 2009.Google Scholar
Cochrane Collaboration, Review Manager 5. http://ims.cochrane.org/revman/download
Accessed 17th January 2011.
Hedges LV. Distribution theory for Glass’s estimator of effect size and related estimators. J Educ Stat. 1981;6:107–28.CrossRefGoogle Scholar
Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks: Sage; 2001.Google Scholar
Sanchez-Meca J, Marin-Martinez F, Chacon-Moscoso S. Effect-size indices for dichotomized outcomes in meta-analysis. Psychol Methods. 2003;8(4):448–67.PubMedCrossRefGoogle Scholar
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRefGoogle Scholar
Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2
index? Psychol Methods. 2006;11(2):193–206.PubMedCrossRefGoogle Scholar
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefGoogle Scholar
StataCorp, Stata version 10. Texas: StataCorp; 2008
Scott-Sheldon LA, Huedo-Medina TB, Warren MR, Johnson BT, Carey MP. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010. J Acquir Immune Defic Syndr. 2011;58(5):489–98.PubMedCrossRefGoogle Scholar
Johnson BT, Scott-Sheldon LA, Smoak ND, Lacroix JM, Anderson JR, Carey MP. Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials. J Acquir Immune Defic Syndr. 2009;51(4):492–501.PubMedCrossRefGoogle Scholar
Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol. 2008;27(3):379–87.PubMedCrossRefGoogle Scholar
Michie S, Prestwick A. Are interventions theory-based? Development of a theory coding scheme. Health Psychol. 2010;29:1–8.PubMedCrossRefGoogle Scholar
Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23:1663–82.PubMedCrossRefGoogle Scholar
Magura S, Kang S, Shapiro JL. Outcomes of intensive AIDS education for male adolescent drug users in jail. J Adolesc Health. 1994;15:457–63.PubMedCrossRefGoogle Scholar
Copenhaver MM, Johnson BT, Lee I-C, Harman JJ, Carey MP. Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31:163–71.PubMedCrossRefGoogle Scholar
Eaton LA, Huedo-Medina TB, Kalichman SC, et al. Meta-analysis of single-session behavioral interventions to prevent sexually transmitted infections: implications for bundling prevention packages. Am J Public Health. 2012;102:e34–44.PubMedCrossRefGoogle Scholar
Pinkerton SD, Holtgrave DR, DiFranceisco WJ, Semaan S, Coyle SL, Johnson-Masotti AP. Cost-Threshold analyses of the national AIDS demonstration research HIV prevention interventions. AIDS. 2000;14:1257–68.PubMedCrossRefGoogle Scholar
Centers for Disease Control and Prevention. A Public health approach for advancing sexual health in the United States: Rationale and options for implementation. Meeting Report of an extramural consultation, Atlanta, GA. CDC, December 2010.
Semaan S, Neumann MS, Hutchins K, D’Anna LH, Kamb ML. Brief counseling for reducing sexual risk and bacterial STIs among drug users: results from project respect. Drug Alcohol Depend. 2010;106:7–15.PubMedCrossRefGoogle Scholar
Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present and future. Lancet. 2010;376:268–84.PubMedCrossRefGoogle Scholar
Deren S, Kang S-Y, Mino M, Guarino H. Conducting peer outreach to migrants: outcomes for drug treatment patients. J Immigrant Minority Health. 2012;14:251–8.CrossRefGoogle Scholar
Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20:143–57.PubMedCrossRefGoogle Scholar
Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counselling in drug treatment centers: Results of a randomized trial. Am J Public Health. 2012;102:1160–7.PubMedCrossRefGoogle Scholar
Volkow ND, Montaner J. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Aff. 2011;30:1411–9.CrossRefGoogle Scholar
Centers of Disease Control and Prevention. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. Mortality and morbidity weekly reports, recommendation and reports 2012; 61(5):1–47.
Copenhaver MM, Lee I-C. Optimizing a community-friendly HIV risk reduction intervention for injection drug users in treatment: a structural equation modeling approach. J Urban Health. 2006;83(6):1132–42.PubMedCrossRefGoogle Scholar